Scientists in have discovered a a drug with the potential to head off the onset of Alzheimer’s disease. Neuro-Bio, a spin off from Oxford University, believes it has identified a molecule that triggers damage at the centre of the brain – damage that can occur as long as 10 – 15 years before eventual sufferers experience symptoms. Their drug, given as a nasal spray is expected to undergo trials in humans.